Your search returned 3 results.

Results
	1.	Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1. [electronic resource] by Lai, E De Lepeleire, I Crumley, T M Liu, F Wenning, L A Michiels, N Vets, E O'Neill, G Wagner, J A Gottesdiener, K Producer: 20070727 In: Clinical pharmacology and therapeutics vol. 81 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-38431055, a novel GPR119 receptor agonist and potential antidiabetes agent, in healthy male subjects. [electronic resource] by Katz, L B Gambale, J J Rothenberg, P L Vanapalli, S R Vaccaro, N Xi, L Polidori, D C Vets, E Sarich, T C Stein, P P Producer: 20111207 In: Clinical pharmacology and therapeutics vol. 90 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	UGT2B17 genetic polymorphisms dramatically affect the pharmacokinetics of MK-7246 in healthy subjects in a first-in-human study. [electronic resource] by Wang, Y-H Trucksis, M McElwee, J J Wong, P H Maciolek, C Thompson, C D Prueksaritanont, T Garrett, G C Declercq, R Vets, E Willson, K J Smith, R C Klappenbach, J A Opiteck, G J Tsou, J A Gibson, C Laethem, T Panorchan, P Iwamoto, M Shaw, P M Wagner, J A Harrelson, J C Producer: 20120904 In: Clinical pharmacology and therapeutics vol. 92 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)